1. Pink Sheet
  2. >>Market Access

Trump Drug Pricing Plan May Include Rebate Pass-Through Push – Novartis CEO

 
• By Sue Sutter

Industry exec Jimenez hopes President Trump’s reform proposals, expected in next three months, will include measures to ensure manufacturer rebates are passed through to patients and encourage outcomes-based reimbursement contracts with payers.

Dollar sign made with drug pills

Novartis AG CEO Joseph Jimenez is hopeful that supply chain reforms aimed at ensuring drug manufacturer discounts are passed through to end users will be part of the Trump Administration’s forthcoming drug pricing proposals.

During the company’s investor day May 31, Jimenez said he expects the administration will come out with a set of...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Pricing Debate

More from Market Access